131 related articles for article (PubMed ID: 30009654)
1. Renal dysfunctions/injury in adult epilepsy patients treated with carbamazepine or valproate.
Hamed SA; Rageh TA; Mohamad AO; Abou Elnour SM
Expert Rev Clin Pharmacol; 2018 Aug; 11(8):819-824. PubMed ID: 30009654
[TBL] [Abstract][Full Text] [Related]
2. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis.
Chuang YC; Chuang HY; Lin TK; Chang CC; Lu CH; Chang WN; Chen SD; Tan TY; Huang CR; Chan SH
Epilepsia; 2012 Jan; 53(1):120-8. PubMed ID: 22085257
[TBL] [Abstract][Full Text] [Related]
3. The effect of antiepileptic drugs on the kidney function and structure.
Hamed SA
Expert Rev Clin Pharmacol; 2017 Sep; 10(9):993-1006. PubMed ID: 28689437
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for sodium valproate-induced renal tubular dysfunction.
Koga S; Kimata T; Yamanouchi S; Tsuji S; Yoshimura K; Araki A; Kaneko K
Clin Exp Nephrol; 2018 Apr; 22(2):420-425. PubMed ID: 28836089
[TBL] [Abstract][Full Text] [Related]
5. [Monitoring of renal function in epileptic children and teenagers treated with valproic acid or carbamazepine in concomitant therapy with tiagabine].
Hurkacz M; Wiela-Hojeńska A; Orzechowska-Juzwenko K; Kozik A; Unolt J
Pol Merkur Lekarski; 2001 Dec; 11(66):480-3. PubMed ID: 11899842
[TBL] [Abstract][Full Text] [Related]
6. Does nephrotoxicity exist in pediatric epileptic patients on valproate or carbamazepine therapy?
Havali C; Gücüyener K; Buyan N; Yılmaz Ü; Gürkaş E; Gülbahar Ö; Demir E; Serdaroğlu A
J Child Neurol; 2015 Mar; 30(3):301-6. PubMed ID: 24958008
[TBL] [Abstract][Full Text] [Related]
7. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
Zeng K; Wang X; Xi Z; Yan Y
Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormones in children with epilepsy during long-term administration of carbamazepine and valproate.
Verrotti A; Laus M; Scardapane A; Franzoni E; Chiarelli F
Eur J Endocrinol; 2009 Jan; 160(1):81-6. PubMed ID: 18984773
[TBL] [Abstract][Full Text] [Related]
9. Renal tubular function in patients receiving anticonvulsant therapy: a long-term study.
Verrotti A; Greco R; Pascarella R; Matera V; Morgese G; Chiarelli F
Epilepsia; 2000 Nov; 41(11):1432-5. PubMed ID: 11077456
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of sex hormones and sperm parameters in male epileptic patients.
Ocek L; Tarhan H; Uludağ FI; Sarıteke A; Köse C; Colak A; Zorlu F; Zorlu Y
Acta Neurol Scand; 2018 Apr; 137(4):409-416. PubMed ID: 29315457
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and tolerability of antiepileptic drugs in 104 girls with Rett syndrome.
Vignoli A; Savini MN; Nowbut MS; Peron A; Turner K; La Briola F; Canevini MP
Epilepsy Behav; 2017 Jan; 66():27-33. PubMed ID: 27988477
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of renal tubular function in children taking anti-epileptic treatment.
Unay B; Akin R; Sarici SU; Gok F; Kurt I; Gokcay E
Nephrology (Carlton); 2006 Dec; 11(6):485-8. PubMed ID: 17199783
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome and anticonvulsants: A comparative study of valproic acid and carbamazepine.
Rakitin A; Kõks S; Haldre S
Seizure; 2016 May; 38():11-6. PubMed ID: 27061880
[TBL] [Abstract][Full Text] [Related]
14. Vascular function and risk factors in children with epilepsy: associations with sodium valproate and carbamazepine.
Keenan N; Sadlier LG; Wiltshire E
Epilepsy Res; 2014 Aug; 108(6):1087-94. PubMed ID: 24893830
[TBL] [Abstract][Full Text] [Related]
15. States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain.
Hamed SA; Fida NM; Hamed EA
Eur J Paediatr Neurol; 2009 May; 13(3):261-8. PubMed ID: 18586538
[TBL] [Abstract][Full Text] [Related]
16. Assessment of atherosclerotic risk among patients with epilepsy on valproic acid, lamotrigine, and carbamazepine treatment.
Zuberi NA; Baig M; Bano S; Batool Z; Haider S; Perveen T
Neurosciences (Riyadh); 2017 Apr; 22(2):114-118. PubMed ID: 28416782
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D Deficiency in Ambulant Children on Carbamazepine or Sodium Valproate Monotherapy.
Sreedharan M; Devadathan K; Mohammed Kunju PA; Sasidharan B; Pillai JP; Vasumathy Amma MA; Muthubeevi S
Indian Pediatr; 2018 Apr; 55(4):307-310. PubMed ID: 29428922
[TBL] [Abstract][Full Text] [Related]
18. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
[TBL] [Abstract][Full Text] [Related]
19. Comparison of body composition in persons with epilepsy on conventional & new antiepileptic drugs.
Sarangi SC; Tripathi M; Kakkar AK; Gupta YK
Indian J Med Res; 2016 Mar; 143(3):323-30. PubMed ID: 27241646
[TBL] [Abstract][Full Text] [Related]
20. An experimental design for finding of minimum dosage of carbamazepine and valproate in preventing of seizure attacks.
Samaei A; Nobahar M; Vafaei AA
Pak J Pharm Sci; 2009 Apr; 22(2):180-3. PubMed ID: 19339229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
